{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:05:14Z","timestamp":1790802314279,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["ZZ0808004"],"award-info":[{"award-number":["ZZ0808004"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973837"],"award-info":[{"award-number":["81973837"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["GZYYGJ2018031"],"award-info":[{"award-number":["GZYYGJ2018031"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["81774296"],"award-info":[{"award-number":["81774296"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC1709904"],"award-info":[{"award-number":["2019YFC1709904"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jep.2021.114180","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T12:54:08Z","timestamp":1620046448000},"page":"114180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications"],"prefix":"10.1016","volume":"276","author":[{"given":"Sha","family":"Di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedong","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zezheng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyou","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/1479164118820714","article-title":"Microvascular complications among patients with diabetes: an emerging health problem in Saudi Arabia","volume":"16","author":"Alwin Robert","year":"2019","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.jep.2021.114180_bib2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.critrevonc.2017.05.008","article-title":"Regulatory effects of berberine on microRNome in Cancer and other conditions","volume":"116","author":"Ayati","year":"2017","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"5","key":"10.1016\/j.jep.2021.114180_bib3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1142\/S0192415X19500496","article-title":"Antidiabetic potential of flavonoids from traditional Chinese medicine: a review","volume":"47","author":"Bai","year":"2019","journal-title":"Am. J. Chin. Med."},{"issue":"1","key":"10.1016\/j.jep.2021.114180_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/endo.140.1.6457","article-title":"c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity","volume":"140","author":"Camp","year":"1999","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib5","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jep.2013.07.025","article-title":"Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells","volume":"149","author":"Cao","year":"2013","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.jep.2021.114180_bib6","first-page":"10267","article-title":"Berberine alleviates chronic inflammation of mouse model of type 2 diabetes by adjusting intestinal microbes and inhibiting TLR4 signaling pathway","volume":"10","author":"Cao","year":"2017","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.jep.2021.114180_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1389200219666180918152241","article-title":"The role of xenobiotic receptors on hepatic glycolipid metabolism","volume":"20","author":"Chen","year":"2019","journal-title":"Curr. Drug Metabol."},{"issue":"12","key":"10.1016\/j.jep.2021.114180_bib8","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.metabol.2009.06.009","article-title":"Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions","volume":"58","author":"Chen","year":"2009","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib9","first-page":"519371","article-title":"Berberine improves glucose homeostasis in streptozotocin-induced diabetic rats in association with multiple factors of insulin resistance","volume":"2011","author":"Chen","year":"2011","journal-title":"Isrn Endocrinol."},{"issue":"4","key":"10.1016\/j.jep.2021.114180_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060213","article-title":"Microarray analyses of glucocorticoid and vitamin D3 target genes in differentiating cultured human podocytes","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jep.2021.114180_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib12","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.kint.2017.04.026","article-title":"Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor \u03b1","volume":"92","author":"Dai","year":"2017","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.jep.2021.114180_bib13","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/med.21578","article-title":"A review of the molecular design and biological activities of RXR agonists","volume":"39","author":"de Almeida","year":"2019","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jep.2021.114180_bib14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.jep.2021.114180_bib15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/ptr.5587","article-title":"Metabolomics study of type 2 diabetes mellitus and the AntiDiabetic effect of berberine in Zucker diabetic fatty rats using Uplc-ESI-Hdms","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother Res."},{"issue":"5","key":"10.1016\/j.jep.2021.114180_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1476-5381.2011.01270.x","article-title":"Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus","volume":"163","author":"Dostalek","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.jep.2021.114180_bib17","first-page":"2057","article-title":"Cytochrome P450: polymorphisms and roles in cancer, diabetes and atherosclerosis","volume":"19","author":"Elfaki","year":"2018","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cbf.1437","article-title":"Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis","volume":"26","author":"Ercan","year":"2008","journal-title":"Cell Biochem. Funct."},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0016-5085(95)90382-8","article-title":"Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus","volume":"109","author":"Frank","year":"1995","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF03347042","article-title":"The protective effect of berberine on \u03b2-cell lipoapoptosis","volume":"34","author":"Gao","year":"2011","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jep.2021.114180_bib21","first-page":"3937893","article-title":"Genetic epidemiology of type 2 diabetes in Mexican mestizos","author":"Garc\u00eda-Chapa","year":"2017","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.jep.2021.114180_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.mce.2015.10.009","article-title":"Risk factors for post-transplant diabetes mellitus in renal transplant: role of genetic variability in the CYP450-mediated arachidonic acid metabolism","volume":"419","author":"Gervasini","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.jep.2021.114180_bib23","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.cmet.2017.04.015","article-title":"Metabolic flexibility in health and disease","volume":"25","author":"Goodpaster","year":"2017","journal-title":"Cell Metabol."},{"key":"10.1016\/j.jep.2021.114180_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2891-13-17","article-title":"Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a review","volume":"13","author":"Grygiel-Gorniak","year":"2014","journal-title":"Nutr. J."},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00228-011-1108-2","article-title":"Repeated administration of berberine inhibits cytochromes P450 in humans","volume":"68","author":"Guo","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12013-015-0525-8","article-title":"Attenuation of streptozotocin-induced lipid profile Anomalies in the heart, brain, and mRNA expression of HMG-CoA reductase by diosgenin in rats","volume":"72","author":"Hao","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"10","key":"10.1016\/j.jep.2021.114180_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/nbt1007-1110","article-title":"Network pharmacology","volume":"25","author":"Hopkins","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jep.2021.114180_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"5295","key":"10.1016\/j.jep.2021.114180_bib29","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1126\/science.274.5295.2100","article-title":"Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma","volume":"274","author":"Hu","year":"1996","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib30","first-page":"436","article-title":"Design of new traditional Chinese medicine herbal formulae for treatment of type 2 diabetes mellitus based on network pharmacology","volume":"15","author":"Hu","year":"2017","journal-title":"Chin. J. Nat. Med."},{"issue":"11","key":"10.1016\/j.jep.2021.114180_bib31","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int. J. Biol. Sci."},{"issue":"5519","key":"10.1016\/j.jep.2021.114180_bib32","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jep.2021.114180_bib33","doi-asserted-by":"crossref","first-page":"E249","DOI":"10.1152\/ajpendo.00478.2015","article-title":"The glucocorticoid receptor: cause of or cure for obesity?","volume":"310","author":"John","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.jep.2021.114180_bib34","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/dc11-1093","article-title":"Sleep architecture and glucose and insulin homeostasis in obese adolescents","volume":"34","author":"Koren","year":"2011","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jep.2021.114180_bib35","first-page":"58","article-title":"SNP in KCNQ1 gene is associated with susceptibility to diabetic nephropathy in subjects with type 2 diabetes in India","volume":"66","author":"Kumar","year":"2018","journal-title":"J. Assoc. Phys. India"},{"issue":"8","key":"10.1016\/j.jep.2021.114180_bib36","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jep.2021.114180_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.pharmtox.41.1.535","article-title":"Interindividual variability in inhibition and induction of cytochrome P450 enzymes","volume":"41","author":"Lin","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib38","first-page":"538","article-title":"[Association of polymorphisms of potassium voltage-gated channel, KQT-like subfamily, member 1 and type 2 diabetes in Jiangsu province, China]","volume":"47","author":"Lin","year":"2013","journal-title":"Zhonghua Yufang Yixue Zazhi"},{"issue":"13","key":"10.1016\/j.jep.2021.114180_bib39","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1111\/bph.12666","article-title":"Uncoupling protein-2 mediates the protective action of berberine against oxidative stress in rat insulinoma INS-1E cells and in diabetic mouse islets","volume":"171","author":"Liu","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.jep.2021.114180_bib40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1507\/endocrj.K10E-043","article-title":"Beneficial effect of berberine on hepatic insulin resistance in diabetic hamsters possibly involves in SREBPs, LXR\u03b1 and PPAR\u03b1 transcriptional programs","volume":"57","author":"Liu","year":"2010","journal-title":"Endocr. J."},{"issue":"Suppl. 3","key":"10.1016\/j.jep.2021.114180_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000448357","article-title":"Fatty acid oxidation and its relation with insulin resistance and associated disorders","volume":"68","author":"Lopaschuk","year":"2016","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.jep.2021.114180_bib42","first-page":"703538","article-title":"Mitochondrial dysfunction and beta-cell failure in type 2 diabetes mellitus","author":"Ma","year":"2012","journal-title":"Exp. Diabetes Res."},{"issue":"10","key":"10.1016\/j.jep.2021.114180_bib43","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.ajpath.2017.06.007","article-title":"Impaired rhodopsin generation in the rat model of diabetic retinopathy","volume":"187","author":"Malechka","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jep.2021.114180_bib44","article-title":"DPP-4 inhibitors promote proliferation and migration of rat brain microvascular endothelial cells under hypoxic\/high-glucose conditions, potentially through the SIRT1\/HIF-1\/VEGF pathway","author":"Mi","year":"2018","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib45","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2174\/1568026616666160617085545","article-title":"Retinoid X receptor ligands with anti-type 2 diabetic activity","volume":"17","author":"Morishita","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib46","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.phymed.2011.12.005","article-title":"Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms","volume":"19","author":"Or","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jep.2021.114180_bib47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1055\/s-0043-115226","article-title":"Aldosterone hypothesis for cognitive impairment in diabetes mellitus","volume":"49","author":"Saha","year":"2017","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib48","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00109-003-0510-3","article-title":"Retinoic acid receptor alpha and retinoid X receptor specific agonists reduce renal injury in established chronic glomerulonephritis of the rat","volume":"82","author":"Schaier","year":"2004","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-014-9889-0","article-title":"The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities","volume":"29","author":"Schram","year":"2014","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.jep.2021.114180_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmet.2013.09.002","article-title":"Genetic and epigenetic control of metabolic health","volume":"2","author":"Schwenk","year":"2013","journal-title":"Mol. Metabol."},{"issue":"10","key":"10.1016\/j.jep.2021.114180_bib51","doi-asserted-by":"crossref","first-page":"17269","DOI":"10.1002\/jcp.28344","article-title":"KCNQ1OT1 affects the progression of diabetic retinopathy by regulating miR-1470 and epidermal growth factor receptor","volume":"234","author":"Shao","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.jep.2021.114180_bib52","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.molmet.2017.06.013","article-title":"Adipocyte glucocorticoid receptor is important in lipolysis and insulin resistance due to exogenous steroids, but not insulin resistance caused by high fat feeding","volume":"6","author":"Shen","year":"2017","journal-title":"Mol. Metabol."},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib53","doi-asserted-by":"crossref","first-page":"E418","DOI":"10.1152\/ajpendo.00218.2018","article-title":"All-trans retinoic acid suppresses bone morphogenetic protein 4 in mouse diabetic nephropathy through a unique retinoic acid response element","volume":"316","author":"Tamaki","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.mvr.2011.09.008","article-title":"High glucose impairs EDHF-mediated dilation of coronary arterioles via reduced cytochrome P450 activity","volume":"82","author":"Tsai","year":"2011","journal-title":"Microvasc. Res."},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ando.2018.03.001","article-title":"Pathophysiology of glucocorticoid signaling","volume":"79","author":"Vitellius","year":"2018","journal-title":"Ann. Endocrinol."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib56","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.bcp.2005.06.016","article-title":"Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: biphasic effect on CYP1A1","volume":"70","author":"Vrzal","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib57","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metabol. Rev."},{"key":"10.1016\/j.jep.2021.114180_bib58","first-page":"285489","article-title":"Effect of berberine on PPAR alpha\/NO activation in high glucose- and insulin-induced cardiomyocyte hypertrophy","author":"Wang","year":"2013","journal-title":"Evid. Based Complement Alternative Med."},{"issue":"35","key":"10.1016\/j.jep.2021.114180_bib59","article-title":"Efficacy and safety of berberine in the treatment of type 2 diabetes with insulin resistance: protocol for a systematic review","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine (Baltim.)"},{"issue":"8","key":"10.1016\/j.jep.2021.114180_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082354","article-title":"Retinoid X receptor antagonists","volume":"19","author":"Watanabe","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib61","first-page":"1104","article-title":"[Compound traditional Chinese medicine in treatment of diabetes]","volume":"44","author":"Wu","year":"2019","journal-title":"Zhongguo Zhongyao Zazhi"},{"issue":"44","key":"10.1016\/j.jep.2021.114180_bib62","doi-asserted-by":"crossref","first-page":"41029","DOI":"10.1074\/jbc.M102824200","article-title":"Stimulation of glucose transport by AMP-activated protein kinase via activation of p38 mitogen-activated protein kinase","volume":"276","author":"Xi","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.jep.2021.114180_bib63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1463-1326.2010.01336.x","article-title":"Diabetes is an inflammatory disease: evidence from traditional Chinese medicines","volume":"13","author":"Xie","year":"2011","journal-title":"Diabetes Obes. Metabol."},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib64","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3748\/wjg.v9.i2.359","article-title":"Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases","volume":"9","author":"Yang","year":"2003","journal-title":"World J. Gastroenterol."},{"issue":"30","key":"10.1016\/j.jep.2021.114180_bib65","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.2174\/1568026616666160530181328","article-title":"Drug repositioning through network pharmacology","volume":"16","author":"Ye","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"10.1016\/j.jep.2021.114180_bib66","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.metabol.2008.01.013","article-title":"Efficacy of berberine in patients with type 2 diabetes mellitus","volume":"57","author":"Yin","year":"2008","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.jep.2021.114180_bib67","first-page":"531","article-title":"[New thoughts on material basis and mechanism of Yin-tonifying traditional Chinese medicine in treatment of diabetes mellitus and its complications]","volume":"45","author":"Yuan","year":"2020","journal-title":"Zhongguo Zhongyao Zazhi"},{"key":"10.1016\/j.jep.2021.114180_bib68","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3389\/fphar.2017.00694","article-title":"System pharmacology-based dissection of the synergistic mechanism of Huangqi and Huanglian for diabetes mellitus","volume":"8","author":"Yue","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.jep.2021.114180_bib69","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.metabol.2009.07.029","article-title":"Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression","volume":"59","author":"Zhang","year":"2010","journal-title":"Metab., Clin. Exp."},{"issue":"1","key":"10.1016\/j.jep.2021.114180_bib70","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11418-012-0654-y","article-title":"Attenuating effect of Fufang Xueshuantong Capsule on kidney function in diabetic nephropathy model","volume":"67","author":"Zhang","year":"2013","journal-title":"J. Nat. Med."},{"issue":"21","key":"10.1016\/j.jep.2021.114180_bib71","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/00029330-200811010-00003","article-title":"Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus","volume":"121","author":"Zhang","year":"2008","journal-title":"Chinese Med J"},{"issue":"24","key":"10.1016\/j.jep.2021.114180_bib72","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1080\/14786419.2014.1001387","article-title":"Tadehaginoside modulates lipogenesis and glucose consumption in HepG2 cells","volume":"29","author":"Zhang","year":"2015","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.jep.2021.114180_bib73","doi-asserted-by":"crossref","DOI":"10.11131\/2018\/101323","article-title":"The role of glucocorticoid receptors in podocytes and nephrotic syndrome","volume":"5","author":"Zhao","year":"2018","journal-title":"Nucl. Recept. Res."},{"issue":"1\u20133","key":"10.1016\/j.jep.2021.114180_bib74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejphar.2010.09.030","article-title":"Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes","volume":"649","author":"Zhou","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jep.2021.114180_bib75","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ejphar.2010.09.030","article-title":"Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes","volume":"649","author":"Zhou","year":"2010","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.jep.2021.114180_bib76","first-page":"1243","article-title":"Effect of berberine on PPARalpha\/delta\/gamma expression in type 2 diabetic rat retinae","volume":"42","author":"Zhou","year":"2007","journal-title":"Yao Xue Xue Bao"},{"issue":"12","key":"10.1016\/j.jep.2021.114180_bib77","first-page":"1243","article-title":"Effect of berberine on PPAR\u03b1\/\u03b4\/\u03b3 expression in type 2 diabetic rat kidney","volume":"42","author":"Zhou","year":"2008","journal-title":"Prog. Mod. Biomed."},{"issue":"6","key":"10.1016\/j.jep.2021.114180_bib78","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1248\/bpb.31.1169","article-title":"Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats","volume":"31","author":"Zhou","year":"2008","journal-title":"Biol. Pharm. Bull."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874121004074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874121004074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:12:34Z","timestamp":1778692354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874121004074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":78,"alternative-id":["S0378874121004074"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2021.114180","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2021.114180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114180"}}